asymmetric triplex metallohelical peptidomimetics (University of Warwick/University of Bradford/Taif University)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameasymmetric triplex metallohelical peptidomimetics (University of Warwick/University of Bradford/Taif University)
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySaudi ArabiaUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWarwick University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A